Evidence map›Paper›PMID 42876057›Full record

ArticleBrain pathology (Zurich, Switzerland)2026

Chronic traumatic encephalopathy in a neuropathologically confirmed Creutzfeldt-Jakob disease cohort.

Lluc Bertran, Iban Aldecoa, Arlène Sindikubwabo, Núria Vidal, Rafael Blesa, Mercè Martínez-Corral, Carlos Nos, Verónica Santiago, Andrea González, Álex Iranzo and 4 more

Abstract read
In one paragraph

Article in Brain pathology (Zurich, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Lluc BertranFaculty of Medicine and Health Science, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.ORCID https://orcid.org/0009-0005-1828-5424
Iban AldecoaDepartment of Pathology, Biomedical Diagnostic Center (CDB), Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0001-5774-7453
Arlène SindikubwaboDepartment of Health Care, HOGENT University of Applied Sciences and Arts, Ghent, Belgium.ORCID https://orcid.org/0009-0000-1210-9132
Núria VidalDepartment of Pathology, Biomedical Diagnostic Center (CDB), Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
Rafael BlesaSant Pau Memory Unit, Hospital de la Santa Creu i Sant Pau - Biomedical Research Institute Sant Pau, Barcelona, Spain.
Mercè Martínez-CorralNeurology Department, HM Sant Jordi Hospital, Barcelona, Spain.
Carlos NosDepartment of Public Health in Catalonia, General Subdirectorate of Surveillance and Response to Emergencies in Public Health, Barcelona, Spain.ORCID https://orcid.org/0000-0002-3830-4910
Verónica SantiagoNeurological Tissue Bank, Biobank-Hospital Clínic-FRCB-IDIBAPS, Barcelona, Spain.
Andrea GonzálezNeurological Tissue Bank, Biobank-Hospital Clínic-FRCB-IDIBAPS, Barcelona, Spain.
Álex IranzoSleep Unit, Neurology Service, FRCB-IDIBAPS, CIBERNED CB06/05/0018-ISCIII, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0002-5618-8271
Christopher J NowinskiBoston University Alzheimer's Disease Research Center and Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
Ann C McKeeBoston University Alzheimer's Disease Research Center and Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0003-2961-7488
Raquel Sánchez ValleAlzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, FRCB-IDIBAPS, CIBERNED CB24/05/0004 ISCIII, Hospital Clínic, Universitat de Barcelona, Institut de Neurociències, Barcelona, Spain.
Laura Molina-PorcelNeurological Tissue Bank, Biobank-Hospital Clínic-FRCB-IDIBAPS, Barcelona, Spain.ORCID https://orcid.org/0000-0003-4068-8578

Funding

José Baselga Research Fund
6 · The paper itself

Abstract

Chronic traumatic encephalopathy (CTE) is a tauopathy associated with repetitive head impacts, experienced most commonly in contact sports; however, its relationship with prion diseases remains unclear. Postmortem CTE screening using phosphorylated tau staining was conducted at the Neurological Tissue Bank of Hospital Clínic-IDIBAPS on hippocampal and frontal cortex samples from patients with neuropathologically confirmed Creutzfeldt-Jakob disease (CJD), blinded to patients' clinical histories. In positive and suggestive cases, the analysis was expanded in accordance with the NINDS/NIBIB consensus criteria for CTE, and clinical and neuropathological information was reviewed. CTE was detected in 3 out of 212 CJD cases (1.4%), all with severe CTE pathology: 2 former soccer players (one of them an elite player) and 1 former rugby player. All had started playing sports between the first and second decades of life and ended in the fifth. The clinical presentation of CJD was heterogeneous, with different initial symptoms in each case. Neuropathological examination revealed an MM1/MV1 histotype in the soccer players and a VV2 histotype in the rugby player, the first- and second-most common variants in CJD, respectively. These three cases illustrate the coexistence of CTE and CJD across heterogeneous clinicopathological presentations. Further studies are needed to determine whether shared mechanisms may contribute to the coexistence of both pathologies.

Indexed as

chronic traumatic encephalopathycontact sportsCreutzfeldt–Jakob diseaseneuropathologyphosphorylated taupostmortem brain analysisprion diseases

Identifiers

PMID42876057
PMCPMC13669554

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.